Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity (Q42775676)
Jump to navigation
Jump to search
scientific article published on 22 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity |
scientific article published on 22 April 2011 |
Statements
1 reference
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity (English)
1 reference
Scott M Wilhelm
1 reference
Jacques Dumas
1 reference
Lila Adnane
1 reference
Mark Lynch
1 reference
Christopher A Carter
1 reference
Gunnar Schütz
1 reference
Karl-Heinz Thierauch
1 reference
Dieter Zopf
1 reference
22 April 2011
1 reference
1 reference
129
1 reference
1
1 reference
245-255
1 reference
Identifiers
1 reference
1 reference